Researchers have controlled the evolution of E. coli bacteria in the lab in order to dramatically increase the amount of plasmid DNA (pDNA) these modified bacteria produce. The advance is significant because pDNA is an essential—and expensive—ingredient in many gene therapies, and the new technique could drive down the cost of these medical treatments.
‘Controlled evolution’ dramatically boosts plasmid DNA production for biomedical manufacturing
